comprehensive -WSS

comprehensive

author：knowledge 2025-10-02 20:59:38 - browse：23

A liver with a smooth and healthy left half and a bumpy, browning right half — chronic disease coverage from STAT — Adobe

Akero Therapeutics said Monday that extending treatment with its experimental drug for the liver disease known as MASH from six months to two years resulted in better outcomes for patients — most notably reductions in liver scarring at a rate three times higher than placebo without worsening other symptoms.

The mid-stage study of the Akero drug called efruxifermin achieved its main goal in September 2022. With longer treatment, more patients with MASH responded to the drug, while those who initially benefited showed durable improvements.

“We’re really pleased with the data. It’s exactly what we were hoping to see,” said Kitty Yale, Akero’s chief development officer, in an interview with STAT. “It’s not just the high response rates, but the fact that responses are sustained and broadened as well.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Bernie Sanders bashes nonprofit hospitals over their tax breaks

entertainment

WSS

A deep dive into Applied Therapeutics’ data, and questions on Cassava

With psoriasis trial ahead, Alumis raises $259 million

Eight reasons why you should get an updated Covid vaccine

How doctors and nurses shape Google's AI

With psoriasis trial ahead, Alumis raises $259 million

Novo Nordisk obesity pill bests Wegovy in early trial

entertainment

comprehensive

hotspot

Medicare details structure of new drug price negotiation program

Takeaways from AdvaMed, the largest medical devices conference

New air purifier tech could be key to improving indoor air quality

Better Therapeutics data on benefit with GLP

At least 13 dead in Texas as scorching temps continue

Akero's treatment for NASH falls short in cirrhosis study

Jerome Adams on the need for new antivirals for Covid

UnitedHealth quietly bought dozens of outpatient centers

Anesthesiologist group: stop taking Ozempic before surgery

Readout LOUD podcast: Merger Mondays, Ozempic panic

Wikipedia

Just how do doctors, lawmakers, and the public define abortion?

IVF, abortion rights issues kick off Biden’s State of the Union

UnitedHealth’s Q3 profit jumps as medical costs rise more slowly

UnitedHealth quietly bought dozens of outpatient centers

What's changing in Medicare's open enrollment this year?

Novo Nordisk obesity pill bests Wegovy in early trial

Wikipedia

leisure time

entertainment

focus